PHASE-II STUDY OF CARBOPLATIN AND CYTOSINE-ARABINOSIDE IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA

被引：5
|
作者：
MULDER, NH [1 ]
SLEIJFER, DT [1 ]
DEVRIES, EGE [1 ]
KOOPS, HS [1 ]
WILLEMSE, PHB [1 ]
机构：
[1] STATE UNIV GRONINGEN HOSP,DEPT SURG ONCOL,9713 EZ GRONINGEN,NETHERLANDS
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1990年 / 116卷 / 03期
关键词：
Chemotherapy; Malignant melanoma;
D O I：
10.1007/BF01612907
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment. © 1990 Springer-Verlag.
引用
收藏
页码：301 / 302
页数：2
相关论文
共 50 条
  • [31] PHASE-II STUDY OF HIGH-DOSE TAMOXIFEN (NSC-180973) IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    INGLE, JN
    AHMANN, DL
    GREEN, SJ
    CANCER, 1982, 49 (07) : 1353 - 1354
  • [32] PHASE-II STUDY OF BLEOMYCIN, ACTINOMYCIN-D, DTIC AND VINDESINE IN DISSEMINATED MALIGNANT-MELANOMA
    MULDER, NH
    SLEIJFER, DT
    SMIT, JM
    DEVRIES, EG
    WILLEMSE, PHB
    KOOPS, HS
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (07): : 879 - 881
  • [33] A PHASE-II TRIAL OF PIROXANTRONE IN DISSEMINATED MALIGNANT-MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    SOSMAN, JA
    FLAHERTY, LE
    LIU, PY
    FLETCHER, W
    THOMPSON, JA
    HANTEL, A
    SONDAK, V
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (01) : 83 - 87
  • [34] PHASE-II TRIAL OF FOTEMUSTINE IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    FALKSON, CI
    FALKSON, G
    FALKSON, HC
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (03) : 251 - 254
  • [35] PHASE-II TRIAL OF TAMOXIFEN IN MALIGNANT-MELANOMA
    LEICHMAN, CG
    SAMSON, MK
    BAKER, LH
    CANCER TREATMENT REPORTS, 1982, 66 (06): : 1447 - 1447
  • [36] PHASE-II STUDY OF DIBROMODULCITOL AND BCNU IN METASTATIC MALIGNANT-MELANOMA
    CLAMON, G
    SINKEY, C
    JOCHIMSEN, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (03): : 244 - 246
  • [37] PHASE-II TRIAL OF PYRAZOFURIN IN MALIGNANT-MELANOMA
    BUDMAN, D
    CURRIE, V
    WITTES, R
    CANCER TREATMENT REPORTS, 1977, 61 (09): : 1733 - 1734
  • [38] TREATMENT OF PRIMARY OR METASTATIC PLEURAL EFFUSION WITH INTRACAVITARY CYTOSINE-ARABINOSIDE AND CISPLATIN - A PHASE-II STUDY
    AITINI, E
    CAVAZZINI, G
    PASQUINI, E
    RABBI, C
    COLOMBO, F
    CANTORE, M
    FATTORI, PP
    PARI, F
    BERTUZZI, A
    SMERIERI, F
    ACTA ONCOLOGICA, 1994, 33 (02) : 191 - 194
  • [39] A PHASE-II STUDY OF CCNU WITH BENZNIDAZOLE FOR METASTATIC MALIGNANT-MELANOMA
    BLEEHEN, NM
    ROBERTS, JT
    NEWMAN, HFV
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08): : 1401 - 1403
  • [40] TREATMENT OF METASTATIC MALIGNANT-MELANOMA WITH TRIMETREXATE - A PHASE-II STUDY
    ODUJINRIN, O
    GOLDBERG, D
    DOROSHOW, J
    LEONG, L
    MARGOLIN, K
    GROVE, W
    CARR, B
    AKMAN, S
    MEDICAL AND PEDIATRIC ONCOLOGY, 1990, 18 (01): : 49 - 52
12345